Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Bapineuzumab for mild to moderate Alzheimer's disease: a meta-analysis of randomized controlled trials.

Abushouk AI, Elmaraezy A, Aglan A, Salama R, Fouda S, Fouda R, AlSafadi AM.

BMC Neurol. 2017 Apr 4;17(1):66. doi: 10.1186/s12883-017-0850-1.

2.

Intermittent hypoxia training protects cerebrovascular function in Alzheimer's disease.

Manukhina EB, Downey HF, Shi X, Mallet RT.

Exp Biol Med (Maywood). 2016 Jun;241(12):1351-63. doi: 10.1177/1535370216649060. Epub 2016 May 10.

3.

Chronic Toxoplasma gondii infection enhances β-amyloid phagocytosis and clearance by recruited monocytes.

Möhle L, Israel N, Paarmann K, Krohn M, Pietkiewicz S, Müller A, Lavrik IN, Buguliskis JS, Schott BH, Schlüter D, Gundelfinger ED, Montag D, Seifert U, Pahnke J, Dunay IR.

Acta Neuropathol Commun. 2016 Mar 16;4:25. doi: 10.1186/s40478-016-0293-8.

4.

Vascular and extravascular distribution of the ATP-binding cassette transporters ABCB1 and ABCC1 in aged human brain and pituitary.

Bernstein HG, Hölzl G, Dobrowolny H, Hildebrandt J, Trübner K, Krohn M, Bogerts B, Pahnke J.

Mech Ageing Dev. 2014 Nov-Dec;141-142:12-21. doi: 10.1016/j.mad.2014.08.003. Epub 2014 Sep 10.

5.

Alzheimer's and ABC transporters--new opportunities for diagnostics and treatment.

Pahnke J, Langer O, Krohn M.

Neurobiol Dis. 2014 Dec;72 Pt A:54-60. doi: 10.1016/j.nbd.2014.04.001. Epub 2014 Apr 16. Review.

6.

Reduced Alzheimer's disease pathology by St. John's Wort treatment is independent of hyperforin and facilitated by ABCC1 and microglia activation in mice.

Hofrichter J, Krohn M, Schumacher T, Lange C, Feistel B, Walbroel B, Heinze HJ, Crockett S, Sharbel TF, Pahnke J.

Curr Alzheimer Res. 2013 Dec;10(10):1057-69.

7.

Impaired mitochondrial energy production and ABC transporter function-A crucial interconnection in dementing proteopathies of the brain.

Pahnke J, Fröhlich C, Krohn M, Schumacher T, Paarmann K.

Mech Ageing Dev. 2013 Oct;134(10):506-15. doi: 10.1016/j.mad.2013.08.007. Epub 2013 Sep 3. Review.

8.

Embedding Aβ42 in heterogeneous membranes depends on cholesterol asymmetries.

Liguori N, Nerenberg PS, Head-Gordon T.

Biophys J. 2013 Aug 20;105(4):899-910. doi: 10.1016/j.bpj.2013.06.046.

9.

Genomic background-related activation of microglia and reduced β-amyloidosis in a mouse model of Alzheimer's disease.

Fröhlich C, Paarmann K, Steffen J, Stenzel J, Krohn M, Heinze HJ, Pahnke J.

Eur J Microbiol Immunol (Bp). 2013 Mar 1;3(1):21-27.

10.

Glutamate system, amyloid ß peptides and tau protein: functional interrelationships and relevance to Alzheimer disease pathology.

Revett TJ, Baker GB, Jhamandas J, Kar S.

J Psychiatry Neurosci. 2013 Jan;38(1):6-23. doi: 10.1503/jpn.110190. Review.

11.

ABC transporters B1, C1 and G2 differentially regulate neuroregeneration in mice.

Schumacher T, Krohn M, Hofrichter J, Lange C, Stenzel J, Steffen J, Dunkelmann T, Paarmann K, Fröhlich C, Uecker A, Plath AS, Sommer A, Brüning T, Heinze HJ, Pahnke J.

PLoS One. 2012;7(4):e35613. doi: 10.1371/journal.pone.0035613. Epub 2012 Apr 24.

12.

Cerebral amyloid-β proteostasis is regulated by the membrane transport protein ABCC1 in mice.

Krohn M, Lange C, Hofrichter J, Scheffler K, Stenzel J, Steffen J, Schumacher T, Brüning T, Plath AS, Alfen F, Schmidt A, Winter F, Rateitschak K, Wree A, Gsponer J, Walker LC, Pahnke J.

J Clin Invest. 2011 Oct;121(10):3924-31. doi: 10.1172/JCI57867. Epub 2011 Sep 1.

13.
14.

Amyloid and Alzheimer's disease.

Lei H.

Protein Cell. 2010 Apr;1(4):312-314. doi: 10.1007/s13238-010-0046-6. No abstract available.

15.

Antiviral agents in Alzheimer's disease: hope for the future?

Wozniak MA, Itzhaki RF.

Ther Adv Neurol Disord. 2010 May;3(3):141-52. doi: 10.1177/1756285610370069. No abstract available.

16.

Automated detection of amyloid-β-related cortical and subcortical signal changes in a transgenic model of Alzheimer's disease using high-field MRI.

Teipel SJ, Kaza E, Hadlich S, Bauer A, Brüning T, Plath AS, Krohn M, Scheffler K, Walker LC, Lotze M, Pahnke J.

J Alzheimers Dis. 2011;23(2):221-37. doi: 10.3233/JAD-2010-101035.

Supplemental Content

Support Center